Karuna Therapeutics, Inc. Marketable Securities
Karuna Therapeutics, Inc. had Marketable Securities of $1.07 billion as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2024-02-22
- 2023-12-31: Marketable Securities $1.07B.
- 2023-09-30: Marketable Securities $1.16B.
- 2023-06-30: Marketable Securities $1.17B.
- 2023-03-31: Marketable Securities $909.76M.
| Period end | Marketable Securities |
|---|---|
| 2023-12-31 | $1.07B 10-K · filed 2024-02-22 |
| 2023-09-30 | $1.16B 10-Q · filed 2023-11-02 |
| 2023-06-30 | $1.17B 10-Q · filed 2023-08-03 |
| 2023-03-31 | $909.76M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $875.72M 10-K · filed 2024-02-22 |
| 2022-09-30 | $563.72M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $271.32M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $266.98M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $287.04M 10-K · filed 2023-02-23 |
| 2021-09-30 | $246.68M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $197.98M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $217.61M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $269.28M 10-K · filed 2022-02-24 |
| 2020-09-30 | $300.11M 10-Q · filed 2020-11-05 |
| 2019-12-31 | $180.47M 10-K · filed 2021-02-25 |